Kuriakose Emil 4
4 · Terns Pharmaceuticals, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
Kuriakose Emil
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2026-01-14+56,250→ 106,615 total - Award
Stock Option (Right to Buy)
[F2]2026-01-14+112,500→ 112,500 totalExercise: $37.18Exp: 2036-01-13→ Common Stock (112,500 underlying)
Footnotes (2)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU"). 25% of the RSUs vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Signature
/s/ David Strauss, as Attorney-in-Fact for Emil Kuriakose|2026-01-16